High altitude cerebral edema: Difference between revisions

Line 1: Line 1:
==Background==
==Background==
*Also known as HACE
*Also known as HACE
*Progressive neurologic deterioration in someone with AMS or HAPE (due to ↑ ICP)  
*Progressive neurologic deterioration in someone with [[acute mountain sickness]] or [[HAPE]] (due to ↑ ICP)  
*Almost never occurs at <8000ft
*Almost never occurs at <8,000ft


==Clinical Features==
==Clinical Features==

Revision as of 19:09, 2 March 2020

Background

  • Also known as HACE
  • Progressive neurologic deterioration in someone with acute mountain sickness or HAPE (due to ↑ ICP)
  • Almost never occurs at <8,000ft

Clinical Features

Differential Diagnosis

High Altitude Illnesses

Evaluation

Head CT of HACE showing diffuse effacement of cerebral sulci and compression of ventricles.
  • Clinical diagnosis

Management

High altitude management algorithm.
  • Immediate descent is the treatment of choice
  • If descent not possible use combination of:
    • Supplemental O2 (goal SpO2 90%)[1]
    • Supportive hyperventilation
    • Dexamethasone 8mg initially (PO, IM, or IV), then 4mg q6hr
    • Acetazolamide 250mg BID (better as ppx)
    • Hyperbaric bag (Gamow bag) if available

Prevention

See Also

References

  1. Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol 2004; 5:136-146.